Impact of formulation on the quality and stability of freeze-dried nanoparticles

• Published in: European journal of pharmaceutics and biopharmaceutics 2021-12, Vol.169, p.256-267
• Main Authors: Luo, Wei-Chung, O'Reilly Beringhs, André, Kim, Rachel, Zhang, William, Patel, Sajal M., Bogner, Robin H., Lu, Xiuling
• Format: Article
• Language: English
• Subjects: Chemistry, Pharmaceutical - methods; Drug Compounding - methods; Excipients - pharmacology; Freeze Drying - methods; Freeze Drying - standards; Humans; Liposomes - pharmacology; Lyoprotectants; Mannitol; Mannitol - pharmacology; Nanoparticles; Nanotechnology; Particle Size; Poly(vinyl alcohol); Quality Improvement; Sucrose; Sucrose - pharmacology; Technology, Pharmaceutical - methods; Technology, Pharmaceutical - trends; Trehalose; Trehalose - pharmacology
• ISSN: 0939-6411; 1873-3441
• DOI: 10.1016/j.ejpb.2021.10.014

[Display omitted] Freeze-drying is an effective approach to improve the long-term stability of nanomedicines. Lyoprotectants are generally considered as requisite excipients to ensure that the quality of nanoparticles is maintained throughout the freeze-drying process. However, depending on the type of nanoparticles, the needs for lyoprotectants or the challenges they face during freeze-drying may be different. In this study, we compared and identified the impact of freeze-drying on key characteristics of three types of nanoparticles: solid lipid nanoparticles (SLNs), polymeric nanoparticles (PNs), and liposomes. Sucrose, trehalose, and mannitol were added to nanoparticle suspensions before freeze-drying. The same conservative freeze-drying conditions with controlled ice nucleation at −8 °C were employed for all formulations. The collapse temperatures of nanoparticle formulations were found to be the same as those of the lyoprotectant added, except PN formulation. Likely the poly(vinyl alcohol) (PVA) in the formulation induced a higher collapse temperature and retardation of drying of PNs. Freeze-drying of both SLNs and liposomes without lyoprotectants increased particle size and polydispersity, which was resolved by adding amorphous disaccharides. Regardless of the addition of lyoprotectants, freeze-drying did not alter the size of PNs possibly due to the protection from PVA. However, lyoprotectants were still necessary to shorten the reconstitution time and reduce the residual moisture. In conclusion, different types of nanoparticles face distinct challenges for freeze-drying, and lyoprotectants differentially affect various stability and quality attributes of freeze-dried nanoparticles.